CB1R in Synthetic Psychoactive Cannabinoids

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Drug Dependence

Interventions

OTHER

[11-C]OMAR

The radiotracer, \[11-C\]OMAR will be administered at no more than 10 micrograms at the beginning of each PET scan.

Trial Locations (1)

Connecticut Mental Health Center, New Haven

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT03539575 - CB1R in Synthetic Psychoactive Cannabinoids | Biotech Hunter | Biotech Hunter